|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sessile serrated adenomas:Demographic,endoscopic and pathological characteristics显示文摘AIM:To study the demographic and endoscopic characteristics of patients with sessile serrated adenoma(SSA) in a single center.METHODS:Patients with SSA were identified by review of the pathology database of Mayo Clinic Arizona from 2005 to 2007.A retrospective chart review was performed to extract data on demographics,polyp characteristics,presence of synchronous adenomatous polyps or cancer,polypectomy methods,and related complications.RESULTS:One hundred and seventy-one(2.9%) of all patients undergoing colonoscopy had a total of 226 SSAs.The mean(SE) size of the SSAs was 8.1(0.4) mm;42% of SSAs were ≤ 5 mm,and 69% were ≤ 9 mm.Fifty-one per cent of SSAs were located in the cecum or ascending colon.Approximately half of the patients had synchronous polyps of other histological types,including hyperplastic and adenomatous polyps.Synchronous adenocarcinoma was present in seven(4%) cases.Ninety-seven percent of polyps were removed by colonoscopy.CONCLUSION:Among patients with colon polyps,2.9% were found to have SSAs.Most of the SSAs were located in the right side and were safely managed by colonoscopy. | Suryakanth R Gurudu Russell I Heigh Giovanni De Petris Evelyn G Heigh Jonathan A Leighton Shabana F Pasha Isaac B Malagon Ananya Das | 2010 | World Journal of Gastroenterology2010，16，27： | 7 |
| 2 | 草药复方Bresol抵抗化合物48/80诱导的肥大细胞脱颗粒及组胺释放:促使肥大细胞稳定的一种非免疫机制(英文)显示文摘目的:研究一种草药复方制剂Bresol对于肥大细胞脱颗粒以及组胺释放的保护作用。方法:使用大鼠腹膜内肥大细胞,在体外经化合物48/80诱导肥大细胞脱颗粒及组胺释放,评估Bresol稳定肥大细胞的作用。结果:显微镜下正常对照组涂片显示较多完整的肥大细胞,有极少量的脱颗粒肥大细胞和微量的组胺释放。阳性对照组中用化合物48/80培养的肥大细胞出现了显著的肥大细胞脱颗粒现象以及高浓度的组胺释放。而100mg/L浓度的Bresol明显抑制了化合物48/80诱导的肥大细胞脱颗粒。此外,Bresol可有效抑制化合物48/80诱导的组胺释放,且抑制效果与剂量有关。结论:Bresol能够在体外抑制化合物48/80诱导的肥大细胞脱颗粒和组胺释放。本研究的发现可解释Bresol对多种过敏疾病有效可能是通过一种非免疫机制。 | Yathiraj Ashwini Mohamed Rafiq Gollapalle L.Viswanatha Subbanna Rajesh Selvam Senthilraja Mohammed Azeemuddin Suryakanth D.Anturlikar Paramesh Rangesh Pralhad S.Patki | 2012 | 中西医结合学报2012，10，6： | 3 |
| 3 | Quality monitoring in colonoscopy: Time to act显示文摘Colonoscopy is the gold standard test for colorectal cancer screening. The primary advantage of colonoscopy as opposed to other screening modalities is the ability to provide therapy by removal of precancerous lesions at the time of detection. However, colonoscopy may miss clinically important neoplastic polyps. The value of colonoscopy in reducing incidence of colorectal cancer is dependent on many factors including, the patient, provider, and facility level. A high quality examination includes adequate bowel preparation, optimal colonoscopy technique, meticulous inspection during withdrawal, identification of subtle flat lesions, and complete polypectomy. Considerable variation among institutions and endoscopists has been reported in the literature. In attempt to diminish this disparity, various approaches have been advocated to improve the quality of colonoscopy. The overall impact of these interventions is not yet well defined. Implementing optimal education and training and subsequently analyzing the impact of these endeavors in improvement of quality will be essential to augment the utility of colonoscopy for the prevention of colorectal cancer. | Mary A Atia Francisco C Ramirez Suryakanth R Gurudu | 2015 | World Journal of Gastrointestinal Endoscopy2015，7，4： | 3 |
| 4 | Capsule Endoscopy in Patients with Implantable Electromedical Devices is Safe显示文摘 | Lucinda A. Harris Stephanie L. Hansel Elizabeth Rajan Komandoor Srivathsan Robert Rea Michael D. Crowell David E. Fleischer Shabana F. Pasha Suryakanth R. Gurudu Russell I. Heigh Arthur D. Shiff Janice K. Post Jonathan A. Leighton Hsu Heng Yen | 2013 | Gastroenterology Research and Practice2013，，： | 2 |
| 5 | Retention of the capsule endoscope: a single-center experience of 1000 capsule endoscopy procedures显示文摘 | Feng Li Suryakanth R. Gurudu Giovanni De Petris Virender K. Sharma Arthur D. Shiff Russell I. Heigh David E. Fleischer Janice Post Paula Erickson Jonathan A. Leighton | 2008 | Gastrointestinal Endoscopy2008，，1： | 2 |
| 6 | Increased adenoma detection rate with system-wide implementation of a split-dose preparation for colonoscopy显示文摘 | Suryakanth R. Gurudu Francisco C. Ramirez M. Edwyn Harrison Jonathan A. Leighton Michael D. Crowell | 2012 | Gastrointestinal Endoscopy2012，，3： | 1 |
| 7 | A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos)显示文摘 | Jerome D. Waye Russell I. Heigh David E. Fleischer Jonathan A. Leighton Suryakanth Gurudu Leslie B. Aldrich Jiayi Li Sanjay Ramrakhiani Steven A. Edmundowicz Dayna S. Early Sreenivasa Jonnalagadda Robert S. Bresalier William R. Kessler Douglas K. Rex | 2010 | Gastrointestinal Endoscopy2010，，3： | 1 |
| 8 | Performance of the patency capsule compared with nonenteroclysis radiologic examinations in patients with known or suspected intestinal strictures显示文摘 | Anitha Yadav Russell I. Heigh Amy K. Hara G. Anton Decker Michael D. Crowell Suryakanth R. Gurudu Shabana F. Pasha David E. Fleischer Lucinda A. Harris Janice Post Jonathan A. Leighton | 2011 | Gastrointestinal Endoscopy2011，，4： | 1 |
| 9 | Increased adenoma detection rate with system-wide implementation of a split-dose preparation for colonoscopy显示文摘 | Suryakanth R. Gurudu Francisco C. Ramirez M. Edwyn Harrison Jonathan A. Leighton Michael D. Crowell | 2012 | Gastrointestinal Endoscopy2012，，3： | 1 |
| 10 | Increased adenoma detection rate with system-wide implementation of a split-dose preparation for colonoscopy显示文摘 | Suryakanth R. Gurudu Francisco C. Ramirez M. Edwyn Harrison Jonathan A. Leighton Michael D. Crowell | 2012 | Gastrointestinal Endoscopy2012，，3： | 1 |
| 11 | Measurement of polypectomy rate by using administrative claims data with validation against the adenoma detection rate显示文摘 | Neal C. Patel Rafiul S. Islam Qing Wu Suryakanth R. Gurudu Francisco C. Ramirez Michael D. Crowell Douglas O. Faigel | 2012 | Gastrointestinal Endoscopy2012，，： | 1 |
| 12 | 725 Measurement of Polypectomy Rate Using Administrative Claims Data With Validation Against the Adenoma Detection Rate显示文摘 | Neal C. Patel Sameer Islam Qing Wu Suryakanth Gurudu Francisco C. Ramirez Michael D. Crowell Douglas O. Faigel | 2012 | Gastrointestinal Endoscopy2012，，4： | 1 |
| 13 | Retention of the capsule endoscope: a single-center experience of 1000 capsule endoscopy procedures显示文摘 | Feng Li Suryakanth R. Gurudu Giovanni De Petris Virender K. Sharma Arthur D. Shiff Russell I. Heigh David E. Fleischer Janice Post Paula Erickson Jonathan A. Leighton | 2008 | Gastrointestinal Endoscopy2008，，1： | 1 |
| 14 | Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation显示文摘 | Christopher D. Wells M. Edwyn Harrison Suryakanth R. Gurudu Michael D. Crowell Thomas J. Byrne Giovanni DePetris Virender K. Sharma | 2008 | Gastrointestinal Endoscopy2008，，2： | 1 |
| 15 | 内镜在隐源性消化道出血中的作用显示文摘隐源性消化道出血(OGLB)的定义是包括结肠镜和/或胃镜(食管胃十二指肠镜检[EGD])在内最初的阴性内镜结果之后持续或反复的不明原因出血。OGIB可以分为2类:(1)隐性OGIB,主要表现为反复性缺铁性贫血和/或反复性大便潜血阳性(FOBT);(2)显性OGIB:主要表现为黑便或便血。 | Suryakanth R. Gurudu 李冰(编译) 杨露绮(审校) | 2006 | 传染病网络动态2006，，11： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员